OpenAI says it filed confidential IPO as it positions itself for AI arms race Ivar AI

Diariobitcoin.com

SUI se dispara un 12% en medio de un rebote del mercado cripto y expectativas de una nueva ola DeFi

Diariobitcoin.com

Zcash vuela un 23% en un solo día: ¿inicio de una nueva era para la privacidad en cripto?

Crypto Briefing

Pentagon adds Alibaba, Baidu, and BYD to military-linked list, expanding it to 188 entities

Crypto Briefing

SpaceX IPO expected to raise $75B, value company at $1.8T

Crypto Briefing

US military launches airstrikes against Iran after helicopter downing near Strait of Hormuz

Crypto Briefing

Iran shuts down Strait of Hormuz after US military strikes

Noticiabrasil.net.br

Concessão de hidrovias destrava potencial logístico há décadas ignorado no Brasil, avaliam analistas

Crypto Briefing

US Army helicopter shot down by Iran near Strait of Hormuz, Trump confirms

Crypto Briefing

Coatue Management’s Thomas Laffont outlines AI IPO wave, predicts trillion-dollar valuations for OpenAI, Anthropic, and SpaceX

Digitimes

AI demand is turning memory chips into rationed assets, Morgan Stanley says

Businessam.be

Italiaanse bank Intesa Sanpaolo kan dankzij overname op één na grootste bank van Europa worden

Foreign Policy

Trump Says More Strikes on Iran Are Coming

Süddeutsche Zeitung

Israel: Israel und Iran greifen einander an

Ig.com.br

EUA iniciam ataques contra o Irã após queda de helicóptero

Shtfplan.com

The Ogallala Aquifer Is Dying – As The Largest Supply Of Groundwater In The United States Vanishes

Crypto Briefing

Chinese government enforces biggest crackdown on offshore trading in decades

Digitimes

AI chip race lifts semiconductor equipment sales to record US$36.55bn

Eldiario.es

EEUU anuncia una oleada de ataques contra Irán tras el derribo de un helicóptero Apache que patrullaba el estrecho de Ormuz

TechRadar

This Microsoft Defender zero-day could give hackers unprecedented access to your system

Diariobitcoin.com

Worldcoin desafía la tendencia bajista con un alza del 12.95% en 24 horas

$Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire$

GlobeNewswire

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire